Vaxart Inc (VXRT)
0.77
-0.07
(-7.89%)
USD |
NASDAQ |
Apr 19, 16:00
0.75
-0.02
(-2.60%)
After-Hours: 20:00
Vaxart Market Cap: 133.87M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 145.35M |
| April 17, 2024 | 150.58M |
| April 16, 2024 | 155.50M |
| April 15, 2024 | 158.06M |
| April 12, 2024 | 158.23M |
| April 11, 2024 | 180.82M |
| April 10, 2024 | 175.60M |
| April 09, 2024 | 180.82M |
| April 08, 2024 | 187.77M |
| April 05, 2024 | 187.77M |
| April 04, 2024 | 196.46M |
| April 03, 2024 | 213.85M |
| April 02, 2024 | 215.59M |
| April 01, 2024 | 226.02M |
| March 28, 2024 | 226.02M |
| March 27, 2024 | 224.28M |
| March 26, 2024 | 212.11M |
| March 25, 2024 | 213.85M |
| March 22, 2024 | 219.07M |
| March 21, 2024 | 213.85M |
| March 20, 2024 | 215.59M |
| March 19, 2024 | 201.68M |
| March 18, 2024 | 201.68M |
| March 15, 2024 | 187.77M |
| March 14, 2024 | 191.25M |
| Date | Value |
|---|---|
| March 13, 2024 | 196.46M |
| March 12, 2024 | 198.20M |
| March 11, 2024 | 199.94M |
| March 08, 2024 | 206.90M |
| March 07, 2024 | 192.99M |
| March 06, 2024 | 202.55M |
| March 05, 2024 | 204.24M |
| March 04, 2024 | 206.77M |
| March 01, 2024 | 210.99M |
| February 29, 2024 | 205.93M |
| February 28, 2024 | 218.59M |
| February 27, 2024 | 214.37M |
| February 26, 2024 | 207.62M |
| February 23, 2024 | 214.37M |
| February 22, 2024 | 236.31M |
| February 21, 2024 | 238.00M |
| February 20, 2024 | 207.62M |
| February 16, 2024 | 201.71M |
| February 15, 2024 | 199.18M |
| February 14, 2024 | 200.02M |
| February 13, 2024 | 200.86M |
| February 12, 2024 | 210.99M |
| February 09, 2024 | 200.86M |
| February 08, 2024 | 199.18M |
| February 07, 2024 | 200.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.657M
Minimum
Sep 26 2019
2.573B
Maximum
Feb 02 2021
399.82M
Average
207.62M
Median
Feb 20 2024
Market Cap Benchmarks
| Novavax Inc | 557.71M |
| aTyr Pharma Inc | 108.40M |
| Allogene Therapeutics Inc | 588.44M |
| AIM ImmunoTech Inc | 23.50M |
| Protalix BioTherapeutics Inc | 84.38M |
Market Cap Related Metrics
| PS Ratio | 12.02 |
| Price to Book Value | 2.316 |
| Price | 0.77 |
| Earnings Yield | -75.32% |